Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:12 AM
Ignite Modification Date:
2025-12-25 @ 2:12 AM
NCT ID:
NCT04091360
Eligibility Criteria:
Inclusion Criteria:
* Male and female patients with moderate to severe COPD, with a post bronchodilator FEV1 of 40 to 80% of predicted and FEV1/FVC ratio of ≤0.70.
* They must have a baseline increase in FEV1 of \>150 mL following four puffs of salbutamol.
* They must have at least a 10 pack-year smoking history, and may be either a current or former smoker.
Exclusion Criteria:
* Patients must be clinically stable without recent COPD exacerbations or hospitalisations.
* They must not have uncontrolled disease or chronic heart failure.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Maximum Age:
80 Years
Study:
NCT04091360
Study Brief:
Protocol Section:
NCT04091360